KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): Results of the Phase 2 ZUMA-2 Study

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

卷 26, 期 3, 页码 S1-S1

ELSEVIER SCIENCE INC

-

Hematology Immunology Transplantation